Back to search
FDAFDA · Food and drugs·Recall number D-1272-2019

Acyclovir Tablets, USP, 400 mg, 100 count bottles, Rx Only Manufactured by: Cadila Healthcare Ltd., India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ USA 08534 NDC 68382-791-01

Published May 15, 2019 · Recall initiated: April 25, 2019

Summary

FDA records drug Class II recall D-1272-2019, published May 15, 2019 and initiated April 25, 2019. Recalling firm: Zydus Pharmaceuticals USA Inc; Status: Terminated; Reported quantity: N/A; Lot: Z804517, Nov 30, 2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg

What to do

Voluntary: Firm initiated · Letter

Get an email if ACYCLOVIR has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ACYCLOVIR
Manufacturer
Zydus Pharmaceuticals USA Inc
Distributor
Nationwide
Lot
Z804517, Nov 30, 2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Acyclovir Tablets, USP, 400 mg, 100 count bottles, Rx Only Manufactured by: Cadila Healthcare Ltd., India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ USA 08534 NDC 68382-791-01 recalled?

Yes. FDA published recall D-1272-2019 on May 15, 2019. Reported hazard: Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ACYCLOVIR.